Scandinavian ChemoTech AB (publ) announced that after more than a year of collaboration, the company and the IR consultant, Jonathan Furelid, have mutually decided to end the collaboration as a result of changing needs for the company regarding its communication. Jonathan thus leaves the management team as of December 31.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.04 SEK | -4.67% |
|
-8.93% | -24.44% |
Jul. 11 | Scandinavian Chemotech Announces Clinical Trial Progress | CI |
Jun. 04 | Scandinavian Chemotech AB Provides Sales Results for the Second Quarter of Fiscal Year 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.44% | 3.47M | |
+3.26% | 209B | |
+6.55% | 183B | |
+31.66% | 158B | |
+34.32% | 114B | |
+5.13% | 67.29B | |
+19.33% | 54.83B | |
-3.30% | 46.88B | |
-4.84% | 38.58B | |
+3.83% | 36.65B |
- Stock Market
- Equities
- CMOTEC B Stock
- News Scandinavian ChemoTech AB
- Scandinavian Chemotech Thanks for the Cooperation with Its IR Consultant Who Leaves the Management Team